The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Bioconjugation Market Compare Between 2026 And 2030?

The bioconjugation market size has experienced significant growth in recent years. The market is set to expand from $6.12 billion in 2025 to $6.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to several factors, including increasing biologics research activity, the expansion of antibody-based therapeutics, the development of diagnostic assays, the rising adoption of protein labeling techniques, and the availability of standardized conjugation kits.

The bioconjugation market is poised for rapid expansion in the coming years, with its size projected to reach $11.12 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.7%. This anticipated growth can be attributed to the increasing development of targeted drug conjugates, a rise in investments in precision medicine research, the expansion of companion diagnostics, the growing application of conjugated biomolecules in imaging, and an increasing demand for scalable conjugation workflows. Throughout the forecast period, significant trends are expected to include the increasing adoption of site-specific conjugation techniques, a rising use of advanced linker chemistries, a growing demand for high-purity conjugation reagents, the expansion of automated conjugation platforms, and an enhanced focus on stability and reproducibility.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33039&type=smp

What Market Drivers Are Helping Shape The Bioconjugation Market Expansion?

The bioconjugation market is expected to expand moving forward, driven by the escalating need for targeted therapeutics. These are medical treatments specifically crafted to identify and act upon disease-causing cells or molecules, thereby enhancing treatment effectiveness and minimizing harm to healthy tissues. The surge in targeted therapeutics is attributed to the rising desire for precision medicine, which enables more exact treatment strategies, leading to improved patient outcomes and fewer adverse reactions. Bioconjugation plays a crucial role in supporting targeted therapeutics by allowing for the precise linkage of drugs to specific targeting molecules, thus facilitating selective delivery to diseased cells and boosting therapeutic efficacy. For instance, in February 2024, information from the West China Hospital, Sichuan University, a China-based medical research center focused on advancing targeted therapies, indicated that over 47 novel targeted therapeutics were approved by the U.S. Food and Drug Administration in 2023. This figure represented about 85.5% of all new drug approvals, highlighting an increasing emphasis on precision-targeted treatment options in the United States. Therefore, the growing demand for targeted therapeutics is propelling the growth of the bioconjugation market.

How Are Different Segment Groups Identified Within The Bioconjugation Market?

The bioconjugation market covered in this report is segmented –

1) By Product And Service: Consumables; Instruments; Service

2) By Biomolecule Type: Antibodies; Proteins; Peptides; Oligonucleotides; Other Biomolecules

3) By Technique: Chemical Conjugation; Enzyme-Mediated Conjugation; Click Chemistry; Photoreactive Crosslinking; Other Techniques

4) By Application: Therapeutics; Research And Development; Diagnostics

5) By End Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CRO) And Contract Manufacturing Organizations (CMOs); Academic And Research Institutes; Hospitals, Clinical And Diagnostic Laboratories

Subsegments:

1) By Consumables: Reagents; Buffers; Linkers; Kits; Resins; Chromatography Materials; Protein Purification Materials

2) By Instruments: Chromatography Systems; Spectroscopy Systems; Electrophoresis Systems; Automated Conjugation Platforms; Imaging Systems; Bioreactors

3) By Service: Custom Conjugation Services; Antibody Modification Services; Protein Labeling Services; Contract Research Services; Analytical Testing Services; Purification Services

Which Trends Are Supporting The Evolution Of The Bioconjugation Market?

Leading companies in the bioconjugation market are prioritizing the creation of advanced platforms, such as site-specific conjugation methods, to enhance drug delivery accuracy, improve coupling stability, and reduce off-target toxicity. Site-specific conjugation methods are bioconjugation techniques that enable the controlled attachment of therapeutic molecules, like drugs or RNAi, to biomolecules such as antibodies, peptides, or oligonucleotides, ensuring reliable activity and safety. For instance, in August 2023, BOCSCI Inc., a US-based provider of research chemicals and bioconjugation services, introduced the XDC bioconjugation platform, a next-generation solution aimed at optimizing bioconjugate synthesis. By employing advanced conjugation strategies, including unnatural amino acid incorporation, engineered cysteine conjugation, enzyme-assisted ligation, and glycoconjugation generation, the platform allows for the precise manufacturing of antibody-drug conjugates, siRNA conjugates, and other targeted drug delivery molecules, thereby empowering researchers to develop safer and more effective biopharmaceuticals.

Which Companies Form The Competitive Landscape Of The Bioconjugation Market?

Major companies operating in the bioconjugation market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Lonza Group AG, Agilent Technologies Inc., Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Vector Laboratories Inc., Promega Corporation, LGC Biosearch Technologies Ltd., TriLink BioTechnologies LLC, Creative PEGWorks Inc., Lumiprobe Corporation, Biotium Inc., Jena Bioscience GmbH, Quanta BioDesign Ltd., Setareh Biotech Inc., Baseclick GmbH, Biosynth Carbosynth Ltd., Glen Research Inc., BroadPharm Inc., and Biorbyt Ltd.

Access The Complete Bioconjugation Market Report:

https://www.thebusinessresearchcompany.com/report/bioconjugation-market-report

Which Region Has The Strongest Presence In The Bioconjugation Market?

North America was the largest region in the bioconjugation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioconjugation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Bioconjugation Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model